Viruslerin Genel Özellikleri

Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Trends Microbiol. 2000;8(9):410–418. doi:10.1016/S0966-842X(00)01830-8.

Baltimore D. Expression of animal virus genomes. Bacteriological Reviews. 1971;35(3):235–241.

Carter JB, Saunders VA. Virology: Principles and Applications. Wiley-Blackwell; 2013:3–48.

Casadevall A, Pirofski L. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 2001;69(12):7195–7200. doi:10.1128/IAI.69.12.7195-7200.2001.

Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312:763–767. doi:10.1038/312763a0.

De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695–747. doi:10.1128/CMR.00102-15.

De Clercq E. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov. 2006;5(12):1015–1025. doi:10.1038/nrd2175.

Dimmock NJ, Easton AJ, Leppard KN. Introduction to Modern Virology. Wiley-Blackwell; 2016.

Domingo E, Parrish CR, Holland JJ. Origin and Evolution of Viruses. Elsevier; 2008.

Fenner F, Bachmann PA, Gibbs EPJ. Veterinary Virology. Academic Press; 2015:1–39.

Flint SJ, Enquist LW, Racaniello VR, et al. Principles of Virology. 4th ed. ASM Press; 2020.

García-Sastre A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology. 2001;279(2):375–384.

ICTV. Virus Taxonomy: 2023 Release. International Committee on Taxonomy of Viruses. https://ictv.global

Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov. 2015;14(9):642–662.

Knipe DM, Howley PM. Fields Virology. 7th ed. Philadelphia: Wolters Kluwer; 2021.

Koonin EV, Dolja VV. Evolution of complexity in the viral world. Nat Rev Microbiol. 2014;12(10):789–802. doi:10.1038/nrmicro3331.

Levine AJ. The birth of the field of mammalian virology. Nat Rev Microbiol. 2006;4(12):984–990.

Murphy FA, Gibbs EPJ, Horzinek MC. Veterinary Virology. Academic Press; 1999:1–52.

Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier; 2020:355–390.

Palese P, Wang TT. Why do influenza virus subtypes die out? A hypothesis. MBio. 2011;2(5):e00150-11.

Payne S. Viruses: From Understanding to Investigation. Academic Press; 2017.

Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30(7):658–670.

Ryu WS. Molecular Virology of Human Pathogenic Viruses. Academic Press; 2016.

Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531–569. doi:10.1146/annurev.biochem.69.1.531.

Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52(6):910–941.

Wagner EK, Hewlett MJ. Basic Virology. Wiley-Blackwell; 2004:1–60.

Wang Y, Zhang L, Wang Q, et al. CRISPR/Cas systems towards next-generation biosensing. TrAC Trends Anal Chem. 2021;136:116198.

ViralZone. ViralZone [Online]. https://viralzone.expasy.org/ (Erişim tarihi: 22.12.2025). The images are licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.

Weiss RA. The discovery of endogenous retroviruses. Retrovirology. 2006;3:67. doi:10.1186/1742-4690-3-67.

WHO (World Health Organization). Laboratory Biosafety Manual. 4th ed. World Health Organization; 2020.

WHO (World Health Organization). Antiviral Medicines. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/antiviral-medicines

Yeşilbağ K. Genel Viroloji. 5. Baskı. Bursa: Medyay Kitabevi; 2023.

Zhou Y, Yang Y, Huang J, et al. Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain. Viruses. 2019;11(1).